Skip to main content
Top
Published in: Journal of Genetic Counseling 5/2018

01-10-2018 | Original Research

Pregnant Genetic Counselors in an Era of Advanced Genomic Tests: What Do the Experts Test Prenatally?

Authors: Shiri Shkedi-Rafid, Yael Hashiloni-Dolev

Published in: Journal of Genetic Counseling | Issue 5/2018

Login to get access

Abstract

Advanced genomic tests in pregnancy, such as chromosomal microarray analysis (CMA), provide higher detection rates yet often produce probabilistic and uncertain information. This study aimed to understand how the most knowledgeable patients, i.e., pregnant genetic counselors, act in their own pregnancies, thereby gaining insight into the impact of patients’ knowledge on the diagnostic process. Seventeen interviews were conducted with Israeli genetic counselors, either pregnant or up to 2 years post-pregnancy. A third of the participants chose not to have CMA while two thirds underwent it despite no detected abnormalities. Although knowledge was the main motivation, counselors varied in the desired degree of information. Two thirds of those opting for CMA wished to have all findings identified whereas roughly one third asked for a targeted platform seeking to avoid uncertain results. Counselors were not quick to adopt new tests such as whole-exome sequencing. Being knowledgeable was described as promoting a sense of control yet also being a source of stress and moral dilemmas. While the basic premise of informed consent is crucial, it does not always make things easier for educated patients. Consequently, raising levels of patient knowledge is only a limited step forward in the search for best practice.
Literature
go back to reference Ahn, J. W., Bint, S., Irving, M. D., Kyle, P. M., Akolekar, R., Mohammed, S. N., et al. (2014). A new direction for prenatal chromosome microarray testing: software-targeting for detection of clinically significant chromosome imbalance without equivocal findings. PeerJ, 2, e354.CrossRefPubMedPubMedCentral Ahn, J. W., Bint, S., Irving, M. D., Kyle, P. M., Akolekar, R., Mohammed, S. N., et al. (2014). A new direction for prenatal chromosome microarray testing: software-targeting for detection of clinically significant chromosome imbalance without equivocal findings. PeerJ, 2, e354.CrossRefPubMedPubMedCentral
go back to reference Al-Jader, L. N., Parry-Langdon, N., & Smith, R. J. (2000). Survey of attitudes of pregnant women towards down syndrome screening. Prenatal Diagnosis, 20(1), 23–29.CrossRefPubMed Al-Jader, L. N., Parry-Langdon, N., & Smith, R. J. (2000). Survey of attitudes of pregnant women towards down syndrome screening. Prenatal Diagnosis, 20(1), 23–29.CrossRefPubMed
go back to reference American College of Obstetricians and Gynecologists. (2013). Committee on genetics: committee opinion no. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstetrics & Gynecology, 122(6), 1374–1377.CrossRef American College of Obstetricians and Gynecologists. (2013). Committee on genetics: committee opinion no. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstetrics & Gynecology, 122(6), 1374–1377.CrossRef
go back to reference Armengol, L., Nevado, J., Serra-Juhé, C., Plaja, A., Mediano, C., Garcia-Santiago, F. A., et al. (2012). Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis. Human Genetics, 131(3), 513–523.CrossRefPubMed Armengol, L., Nevado, J., Serra-Juhé, C., Plaja, A., Mediano, C., Garcia-Santiago, F. A., et al. (2012). Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis. Human Genetics, 131(3), 513–523.CrossRefPubMed
go back to reference Bernhardt, B. A., Soucier, D., Hanson, K., Savage, M. S., Jackson, L., & Wapner, R. J. (2013). Women’s experiences receiving abnormal prenatal chromosomal microarray testing results. Genetics in Medicine, 15(2), 139–145.CrossRefPubMed Bernhardt, B. A., Soucier, D., Hanson, K., Savage, M. S., Jackson, L., & Wapner, R. J. (2013). Women’s experiences receiving abnormal prenatal chromosomal microarray testing results. Genetics in Medicine, 15(2), 139–145.CrossRefPubMed
go back to reference Bernhardt, B. A., Kellom, K., Barbarese, A., Faucett, W. A., & Wapner, R. J. (2014). An exploration of genetic counselors’ needs and experiences with prenatal chromosomal microarray testing. Journal of Genetic Counseling, 23(6), 938–947.CrossRefPubMedPubMedCentral Bernhardt, B. A., Kellom, K., Barbarese, A., Faucett, W. A., & Wapner, R. J. (2014). An exploration of genetic counselors’ needs and experiences with prenatal chromosomal microarray testing. Journal of Genetic Counseling, 23(6), 938–947.CrossRefPubMedPubMedCentral
go back to reference Brady, P. D., Delle Chiaie, B., Christenhusz, G., Dierick, K., Van Den Bogaert, K., Menten, B., et al. (2014). A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. Genetics in Medicine, 16(6), 469–476.CrossRefPubMed Brady, P. D., Delle Chiaie, B., Christenhusz, G., Dierick, K., Van Den Bogaert, K., Menten, B., et al. (2014). A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. Genetics in Medicine, 16(6), 469–476.CrossRefPubMed
go back to reference Cavalli, P., Cavallari, U., & Novelli, A. (2012). Array CGH in routine prenatal diagnosis practice. Prenatal Diagnosis, 32(7), 708–709 author reply 711-712.CrossRefPubMed Cavalli, P., Cavallari, U., & Novelli, A. (2012). Array CGH in routine prenatal diagnosis practice. Prenatal Diagnosis, 32(7), 708–709 author reply 711-712.CrossRefPubMed
go back to reference Drury, S., Williams, H., Trump, N., GOSgene, Lench, N., Scott, R. H., et al. (2015). Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities. Prenatal Diagnosis, 35(10), 1010–1017.CrossRefPubMed Drury, S., Williams, H., Trump, N., GOSgene, Lench, N., Scott, R. H., et al. (2015). Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities. Prenatal Diagnosis, 35(10), 1010–1017.CrossRefPubMed
go back to reference Glaser, B. G., & Strauss, A. L. (1967). Grounded theory: the discovery of grounded theory. New York: de Gruyter. Glaser, B. G., & Strauss, A. L. (1967). Grounded theory: the discovery of grounded theory. New York: de Gruyter.
go back to reference Hashiloni-Dolev, Y. (2007). A life (un)worthy of living: reproductive genetics in Israel and Germany. Series: International Library of Ethics, Law and the New Medicine (Vol. 34, p. 195). Dordrecht: Springer. Hashiloni-Dolev, Y. (2007). A life (un)worthy of living: reproductive genetics in Israel and Germany. Series: International Library of Ethics, Law and the New Medicine (Vol. 34, p. 195). Dordrecht: Springer.
go back to reference Hillman, S. C., Skelton, J., Quinlan-Jones, E., Wilson, A., & Kilby, M. D. (2013a). “If it helps…”: the use of microarray technology in prenatal testing: patient and partners reflections. American Journal of Medical Genetics Part A, 161A(7), 1619–1627.CrossRefPubMed Hillman, S. C., Skelton, J., Quinlan-Jones, E., Wilson, A., & Kilby, M. D. (2013a). “If it helps…”: the use of microarray technology in prenatal testing: patient and partners reflections. American Journal of Medical Genetics Part A, 161A(7), 1619–1627.CrossRefPubMed
go back to reference Hillman, S., McMullan, D., Hall, G., Togneri, F. S., James, N., & Maher, E. J. (2013b). Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology, 41(6), 610–620.CrossRef Hillman, S., McMullan, D., Hall, G., Togneri, F. S., James, N., & Maher, E. J. (2013b). Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology, 41(6), 610–620.CrossRef
go back to reference Jaques, A. M., Sheffield, L. J., & Halliday, J. L. (2005). Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome. Prenatal Diagnosis, 25(8), 656–664.CrossRefPubMed Jaques, A. M., Sheffield, L. J., & Halliday, J. L. (2005). Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome. Prenatal Diagnosis, 25(8), 656–664.CrossRefPubMed
go back to reference Kalynchuk, E. J., Althouse, A., Parker, L. S., Saller Jr., D. N., & Rajkovic, A. (2015). Prenatal whole-exome sequencing: parental attitudes. Prenatal Diagnosis, 35(10), 1030–1036.CrossRefPubMed Kalynchuk, E. J., Althouse, A., Parker, L. S., Saller Jr., D. N., & Rajkovic, A. (2015). Prenatal whole-exome sequencing: parental attitudes. Prenatal Diagnosis, 35(10), 1030–1036.CrossRefPubMed
go back to reference Mackie, F. L., Carss, K. J., Hillman, S. C., Hurles, M. E., & Killy, M. D. (2014). Exome sequencing in fetuses with structural malformations. Journal of Clinical Medicine, 3(3), 747–762.CrossRefPubMedPubMedCentral Mackie, F. L., Carss, K. J., Hillman, S. C., Hurles, M. E., & Killy, M. D. (2014). Exome sequencing in fetuses with structural malformations. Journal of Clinical Medicine, 3(3), 747–762.CrossRefPubMedPubMedCentral
go back to reference McGillivray, G., Rosenfeld, J. A., McKinlay Gardner, R. J., & Gillam, L. H. (2012). Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing. Prenatal Diagnosis, 32(4), 389–395.CrossRefPubMed McGillivray, G., Rosenfeld, J. A., McKinlay Gardner, R. J., & Gillam, L. H. (2012). Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing. Prenatal Diagnosis, 32(4), 389–395.CrossRefPubMed
go back to reference Mikhaelian, M., Veach, P. M., MacFarlane, I., LeRoy, B. S., & Bower, M. (2013). Prenatal chromosomal microarray analysis: a survey of prenatal genetic counselors’ experiences and attitudes. Prenatal Diagnosis, 33(4), 371–377.PubMed Mikhaelian, M., Veach, P. M., MacFarlane, I., LeRoy, B. S., & Bower, M. (2013). Prenatal chromosomal microarray analysis: a survey of prenatal genetic counselors’ experiences and attitudes. Prenatal Diagnosis, 33(4), 371–377.PubMed
go back to reference Pangalos, C., Hagnefelt, B., Lilakos, K., & Konialis, C. (2016). First applications of a targeted exome sequencing approach in fetuses with ultrasound abnormalities reveals an important fraction of cases with associated gene defects. PeerJ, 4, e1955.CrossRefPubMedPubMedCentral Pangalos, C., Hagnefelt, B., Lilakos, K., & Konialis, C. (2016). First applications of a targeted exome sequencing approach in fetuses with ultrasound abnormalities reveals an important fraction of cases with associated gene defects. PeerJ, 4, e1955.CrossRefPubMedPubMedCentral
go back to reference Prainsack, B., & Firestine, O. (2006). Science for survival: biotechnology regulation in Israel. Science and Public Policy, 33(1), 33–46.CrossRef Prainsack, B., & Firestine, O. (2006). Science for survival: biotechnology regulation in Israel. Science and Public Policy, 33(1), 33–46.CrossRef
go back to reference Rosenfeld, J. A., Coe, B. P., Eichler, E. E., Cuckle, H., & Shafer, L. G. (2012). Estimates of penetrance for recurrent pathogenic copy-number variations. Genetics in Medicine, 15(6), 478–481.CrossRefPubMedPubMedCentral Rosenfeld, J. A., Coe, B. P., Eichler, E. E., Cuckle, H., & Shafer, L. G. (2012). Estimates of penetrance for recurrent pathogenic copy-number variations. Genetics in Medicine, 15(6), 478–481.CrossRefPubMedPubMedCentral
go back to reference Shkedi-Rafid, S., Fenwick, A., Dheensa, S., Wellesley, D., & Lucassen, A. M. (2016). What results to disclose, when, and who decides? Healthcare professionals’ views on prenatal chromosomal microarray analysis. Prenatal Diagnosis, 36(3), 252–259.CrossRefPubMedPubMedCentral Shkedi-Rafid, S., Fenwick, A., Dheensa, S., Wellesley, D., & Lucassen, A. M. (2016). What results to disclose, when, and who decides? Healthcare professionals’ views on prenatal chromosomal microarray analysis. Prenatal Diagnosis, 36(3), 252–259.CrossRefPubMedPubMedCentral
go back to reference Sukenik-Halevy, R., Ludman, M. D., Ben-Shachar, S., & RaasRothschild, A. (2016). The time-consuming demands of the practice of medical genetics in the era of advanced genomic testing. Genetics in Medicine, 18(4), 372–377.CrossRefPubMed Sukenik-Halevy, R., Ludman, M. D., Ben-Shachar, S., & RaasRothschild, A. (2016). The time-consuming demands of the practice of medical genetics in the era of advanced genomic testing. Genetics in Medicine, 18(4), 372–377.CrossRefPubMed
go back to reference Thomson, R., Edwards, A., & Grey, J. (2005). Risk communication in the clinical consultation. Clinical Medicine (London, England), 5(5), 465–469.CrossRef Thomson, R., Edwards, A., & Grey, J. (2005). Risk communication in the clinical consultation. Clinical Medicine (London, England), 5(5), 465–469.CrossRef
go back to reference van der Steen, S. L., Diderich, K. E., Riedijk, S. R., Vernagen-Visser, J., Govaerts, L. C., Joosten, M., et al. (2015). Pregnant couples at increased risk for common aneuploidies choose maximal information from invasive genetic testing. Clinal Genetics, 88(1), 25–31.CrossRef van der Steen, S. L., Diderich, K. E., Riedijk, S. R., Vernagen-Visser, J., Govaerts, L. C., Joosten, M., et al. (2015). Pregnant couples at increased risk for common aneuploidies choose maximal information from invasive genetic testing. Clinal Genetics, 88(1), 25–31.CrossRef
go back to reference Vanakker, O., Vilain, C., Janssens, K., Van der Aa, N., Smith, G., Bandelier, C., et al. (2014). Implementation of genomic arrays in prenatal diagnosis: the Belgian approach to meet the challenges. European Journal of Medical Genetics, 57(4), 151–156.CrossRefPubMed Vanakker, O., Vilain, C., Janssens, K., Van der Aa, N., Smith, G., Bandelier, C., et al. (2014). Implementation of genomic arrays in prenatal diagnosis: the Belgian approach to meet the challenges. European Journal of Medical Genetics, 57(4), 151–156.CrossRefPubMed
go back to reference Walser, S. A., Werner-Lin, A., Russell, A., Wapner, R. J., & Bernhardt, B. A. (2016). “Something extra on chromosome 5”: parents’ understanding of positive prenatal chromosomal microarray analysis (CMA) results. Journal of Genetic Counseling, 25(5), 1116–1126.CrossRefPubMedPubMedCentral Walser, S. A., Werner-Lin, A., Russell, A., Wapner, R. J., & Bernhardt, B. A. (2016). “Something extra on chromosome 5”: parents’ understanding of positive prenatal chromosomal microarray analysis (CMA) results. Journal of Genetic Counseling, 25(5), 1116–1126.CrossRefPubMedPubMedCentral
go back to reference Werner-Lin, A., Walser, S., Barg, F. K., & Bernhardt, B. A. (2017). “They can’t find anything wrong with him, yet”: mothers’ experiences of parenting an infant with a prenatally diagnosed copy number variant (CNV). American Journal of Medical Genetics Part A, 173(2), 444–451.CrossRefPubMed Werner-Lin, A., Walser, S., Barg, F. K., & Bernhardt, B. A. (2017). “They can’t find anything wrong with him, yet”: mothers’ experiences of parenting an infant with a prenatally diagnosed copy number variant (CNV). American Journal of Medical Genetics Part A, 173(2), 444–451.CrossRefPubMed
Metadata
Title
Pregnant Genetic Counselors in an Era of Advanced Genomic Tests: What Do the Experts Test Prenatally?
Authors
Shiri Shkedi-Rafid
Yael Hashiloni-Dolev
Publication date
01-10-2018
Publisher
Springer US
Published in
Journal of Genetic Counseling / Issue 5/2018
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-018-0234-8

Other articles of this Issue 5/2018

Journal of Genetic Counseling 5/2018 Go to the issue